"LUTS is an important health care burden, and health care professionals should be screening for its presence in men at risk," writes Steven A. Kaplan, MD.
Steven A. Kaplan, MD
Advertisement
Dr. Kaplan, a member of the Urology Times Editorial Council, is E. Darracott Vaughan Jr. Professor of Urology at Weill Cornell Medical College and and director of the Iris Cantor Men’s Health Center, New York Presbyterian Hospital, New York.
Articles by Steven A. Kaplan, MD
The management of BPH has had an interesting roller coaster ride over the past 25 years with new medicines, minimally invasive surgical therapies, and a host of novel surgical technologies, including lasers and bipolar electrosurgery.
Advertisement
Latest Updated Articles
- LUTS’ burden may extend to cardiac events
Published: September 1st 2016 | Updated:
- New tech may bring exciting era in BPH
Published: September 1st 2015 | Updated:
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants clearance to Hugo robotic-assisted surgery system for urologic procedures
2
Apalutamide is linked to fewer CNS-related conditions in patients with nmCRPC
3
Prostate MRI is linked with higher sensitivity, NPV vs micro-ultrasound in pilot study
4
BOND-003: Cretostimogene yields durable 24-month responses in high-grade NMIBC
5
